- Home
- DHC vs NAGE Comparison
DHC vs NAGE Comparison
Compare DHC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- NAGE
- Stock Information
- Founded
- DHC 1998
- NAGE 1999
- Country
- DHC United States
- NAGE United States
- Employees
- DHC N/A
- NAGE N/A
- Industry
- DHC Real Estate Investment Trusts
- NAGE Medicinal Chemicals and Botanical Products
- Sector
- DHC Real Estate
- NAGE Health Care
- Exchange
- DHC Nasdaq
- NAGE Nasdaq
- Market Cap
- DHC 757.5M
- NAGE 861.0M
- IPO Year
- DHC N/A
- NAGE N/A
- Fundamental
- Price
- DHC $3.75
- NAGE $12.83
- Analyst Decision
- DHC Hold
- NAGE Strong Buy
- Analyst Count
- DHC 3
- NAGE 3
- Target Price
- DHC $4.50
- NAGE $16.67
- AVG Volume (30 Days)
- DHC 900.6K
- NAGE 1.0M
- Earning Date
- DHC 07-31-2025
- NAGE 08-06-2025
- Dividend Yield
- DHC 1.07%
- NAGE N/A
- EPS Growth
- DHC N/A
- NAGE N/A
- EPS
- DHC N/A
- NAGE 0.18
- Revenue
- DHC $1,511,515,000.00
- NAGE $107,925,000.00
- Revenue This Year
- DHC $3.98
- NAGE $26.21
- Revenue Next Year
- DHC $4.50
- NAGE $20.91
- P/E Ratio
- DHC N/A
- NAGE $71.52
- Revenue Growth
- DHC 5.33
- NAGE 29.77
- 52 Week Low
- DHC $2.00
- NAGE $2.41
- 52 Week High
- DHC $4.24
- NAGE $14.69
- Technical
- Relative Strength Index (RSI)
- DHC 69.18
- NAGE N/A
- Support Level
- DHC $3.50
- NAGE N/A
- Resistance Level
- DHC $3.82
- NAGE N/A
- Average True Range (ATR)
- DHC 0.16
- NAGE 0.00
- MACD
- DHC -0.01
- NAGE 0.00
- Stochastic Oscillator
- DHC 75.44
- NAGE 0.00
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs. Majority of revenue is from SHOP segment.
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.